Clinical Trial Update: Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing oxytocin or galantamine versus placebo for negative symptoms and cognitive impairment in schizophrenia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Galantamine (galantamine)
• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02